This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Global Kidney Dialysis Equipment And Supplies Industry

'Big Three' Rule the Roost II-23

Global Leaders in Dialysis Products Market (2012) II-23

Table 17: Leading Players in the Global Dialysis Products

Market (2011): Percentage Share Breakdown of Value Sales

for Fresenius Medical Care, Baxter, Gambro, and Others

(includes corresponding Graph/Chart) II-24

Table 18: Leading Players in the Global Dialysis Market

(2011): Percentage Share Breakdown by Number of Patients

Treated for Fresenius Medical Care, DaVita, Diaverum,

Liberty Diagnostics Holdings Inc., Kuratorium für Dialyse

and Others (includes corresponding Graph/Chart) II-24

Table 19: Leading Players in the Global Hemodialysis

Products Market (2011): Percentage Share Breakdown of Value

Sales for Fresenius Medical Care, Gambro, Baxter, and Others

(includes corresponding Graph/Chart) II-25

Table 20: Leading Players in the Global Peritoneal Dialysis

Products Market (2011): Percentage Share Breakdown of Value

Sales for Baxter, Fresenius Medical Care, and Others

(includes corresponding Graph/Chart) II-25

Table 21: Leading Players in the Global Dialyzers Market

(2011): Total Number of Patients Treated for Fresenius,

DaVita, Diaverum, Liberty Diagnostics Holdings Inc., and

Kuratorium fur Dialyse (includes corresponding Graph/Chart) II-26

Competitive Assessment of Leading players II-26

5. INTRODUCTION TO DIALYSIS II-28

Dialysis - A Historical Perspective II-28

Kidney Disorders Addressed Through Dialysis II-29

Renal Failure II-29

Acute Renal Failure II-29

Chronic Renal Failure II-29

Renal Failure Caused by Diabetes II-30

Metabolic Disturbances in Chronic Renal Failure II-30

End-Stage Renal Disease II-30

Established Renal Failure II-30

Dialysis Methods II-31

Hemodialysis II-31

Side Effects Associated with Hemodialysis II-32

Cross-contaminated Hemodialysis Equipment Lead to

Bloodstream Infections II-32

Drugs Administered During Hemodialysis II-32

Automated Hemodialysis System II-32

Nocturnal Hemodialysis - A Promising Technique for Dialysis II-33

Peritoneal Dialysis II-33

Issues Related to Peritoneal Dialysis II-34

Types of Peritoneal Dialysis II-34

Continuous Peritoneal Dialysis (CAPD) II-34

Intermittent PD (IPD) II-35

Continuous Cycling Peritoneal Dialysis (CCPD) II-35

PD Plus Therapy II-35

Kidney Transplant: An Alternative to Dialysis II-35

4 of 24

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,856.78 -278.94 -1.54%
S&P 500 2,071.26 -29.78 -1.42%
NASDAQ 4,927.37 -55.4390 -1.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs